Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $70 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Olivia Brayer has reiterated a Neutral rating on Gilead Sciences (NASDAQ:GILD) and maintained a $70 price target.
September 09, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated a Neutral rating for Gilead Sciences, maintaining a $70 price target. This suggests that the analyst does not expect significant short-term price movement.
The reiteration of a Neutral rating and maintenance of the $70 price target by Cantor Fitzgerald indicates that the analyst does not foresee significant changes in Gilead's stock price in the short term. This suggests stability rather than volatility, which is why the score is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100